The Applications and Influences of Transthoracic Echocardiography in Stroke Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04788602

Enrollment

2000

Registered

2021-03-09

Start date

2019-01-01

Completion date

2027-12-31

Last updated

2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the Impact of Echocardiography on the Recurrence of Stroke

Brief summary

Transthoracic echocardiography (TTE) is known to be an effective modality in assessing cardiac function as well as the structure of the heart. It was estimated that between 15% and 30% of ischemic strokes were due to a cardioembolic source, Therefore, TTE has been assumed as an important screening tool in patients with ischemic stroke, as atrial fibrillation is one of the leading risk factors. However, current guidelines have little evidence in whether performing TTE can alter clinical management and prevent a future stroke. We aim to present the association of performing TTE and clinical outcomes in stroke patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Inclusion criteria

* patients with acute stroke and receiving echocardiography

Exclusion criteria

* patients with acute stroke and not receiving echocardiography

Design outcomes

Primary

Measure	Time frame	Description
recurrent stroke	one year	the correlation between the echocardiography and recurrence of stroke

Countries

Taiwan

Outcome results